S810 Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn's Disease. (October 2022)

• Record Type: Journal Article
• Authors: Panés, Julian; Rubin, David T.; Sands, Bruce E.; Reinisch, Walter; D'Haens, Geert; Sahoo, Aparna; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J.; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; Andrews, Jane; Feagan, Brian G.; Gomez, Mario; Terry, Natalie
• Other Names: Afzali Anita presenter.
• Is Part Of: American journal of gastroenterology. Volume 117:Number 10(2022)supplement 10S
• Page Start: e580
• Page End: e580
• Publication Date: 2022-10
• Subjects: Stomach -- Diseases -- Periodicals; Intestines -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Gastrointestinal Diseases -- Periodicals; Electronic journals; Periodicals; 616.33
• DOI: 10.14309/01.ajg.0000859880.63738.dd
• Languages: English
• ISSNs: 0002-9270